Determining the relationship of p16 INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy.

MLA

Rosko, Ashley E., et al. “Determining the Relationship of P16 INK4a and Additional Molecular Markers of Aging with Clinical Frailty in Hematologic Malignancy.” Journal of Cancer Survivorship : Research and Practice, vol. 18, no. 4, Aug. 2024, pp. 1168–78. EBSCOhost, https://doi.org/10.1007/s11764-024-01591-6.

APA

Rosko, A. E., Elsaid, M. I., Woyach, J., Islam, N., Lepola, N., Urrutia, J., Christian, L. M., Presley, C., Mims, A., & Burd, C. E. (2024). Determining the relationship of p16 INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy. Journal of Cancer Survivorship : Research and Practice, 18(4), 1168–1178. https://doi.org/10.1007/s11764-024-01591-6

Chicago

Rosko, Ashley E, Mohamed I Elsaid, Jennifer Woyach, Nowshin Islam, Noah Lepola, Jazmin Urrutia, Lisa M Christian, Carolyn Presley, Alice Mims, and Christin E Burd. 2024. “Determining the Relationship of P16 INK4a and Additional Molecular Markers of Aging with Clinical Frailty in Hematologic Malignancy.” Journal of Cancer Survivorship : Research and Practice 18 (4): 1168–78. doi:10.1007/s11764-024-01591-6.